Autocrine signaling

Autocrine signaling is a way that cells talk to themselves. In this process, a cell makes and sends out a special chemical, called an autocrine agent. This chemical then attaches to special parts on the same cell called autocrine receptors. When this happens, it can cause changes inside the cell.

This type of signaling is different from other ways cells communicate, like paracrine signaling, where cells send messages to nearby cells, or endocrine signaling, where hormones travel through the blood to distant parts of the body.

Autocrine signaling helps cells control many important jobs, like growing, dividing, and responding to their surroundings. It is one of the many clever ways that our bodies work together to stay healthy.

Examples

Cells can send messages to themselves in a special way. For example, a type of cell called a monocyte makes something called interleukin-1 when it is stimulated from outside. This interleukin-1 then attaches to special parts on the same cell that made it, changing how the cell works.

Another example happens with a type of immune cell called a T cell. When a T cell becomes active, it changes its receptors for a substance called IL-2. The cell then releases IL-2, which attaches to its new receptors. This helps the T cell grow and work better, allowing it to help other cells fight germs.

Cancer

Tumor development is a complex process that needs cell division, growth, and survival. Tumors can help themselves grow and survive by making and using their own growth and survival signals. This self-signaling is important for starting cancer and keeping it going.

The Wnt signaling pathway normally helps control whether certain proteins stay around or get broken down. Changes in this pathway, caused by mutations, can lead to many types of human cancer. In colorectal cancer, these changes help cancer proteins stick around longer, which promotes cancer growth. In breast cancer, interrupting this pathway can reduce cancer cell growth and survival. This suggests that targeting this pathway might improve cancer treatments.

Interleukin 6 (IL-6) is important for many cell functions, including growth and survival. Studies show that autocrine IL-6 signaling is important in lung and breast cancers. For example, in lung cancer, a specific protein called STAT3 is often active because of IL-6 signaling. In breast cancers where a protein called HER2 is too abundant, IL-6 signaling helps these cancers grow and survive. Research also shows that high levels of IL-6 in the blood can be linked to worse outcomes in breast cancer patients.

Another important agent in cancer signaling is vascular endothelial growth factor (VEGF). VEGF helps cancer cells survive and move around. It was thought VEGF only helped form new blood vessels, but research shows it also helps cancer cells survive and spread directly.

Autocrine signaling also helps cancer spread to other parts of the body. For example, a signaling loop involving PDGFR helps cancer cells change their shape and move, which is important for spreading.

Understanding these signaling pathways opens new doors for cancer treatments. For example, targeting the Wnt pathway, VEGF signaling, or the HER2–IL-6–STAT3 loop might offer new ways to fight cancer. Also, interfering with PDGFR signaling could help stop cancer spread. Researchers are also looking at ways to use drugs that activate certain signals in cancer cells to make them die more easily.